Navigation Links
Inhaled Steriods Used as Preventive Treatment Post 9/11
Date:10/24/2007

arison group of firefighters who did not participate in the ICS treatment but who were matched for similar exposures and pretreatment pulmonary function.

A total of 2,708 firefighters agreed to participate, but only 158 completed the 4 weeks of treatment (participant totals have been revised since abstract submission). Those who did not complete the treatment cited fear of steroid use and lack of immediate effect. Despite reporting more unprotected hours without a respirator, results showed that the treated group had significantly greater declines in respiratory symptoms and greater quality of life when compared with the untreated firefighters. In addition, revised data analysis showed a small but significant improvement in the lung function of the treated group, as well.

"In situations like the World Trade Center collapse, significant exposure and symptoms are both risk factors for the development of multiple pulmonary disorders," said Dr. Prezant. "The first line of defense must always be respiratory protection, but ICS are a useful adjunct, and we would encourage their use to be considered during emergency conditions where rescues must be made and respiratory protections may be less than adequate, or when early symptoms occur."

"Respiratory illness continues to plague those who were present when the World Trade Center collapsed," said Alvin V. Thomas, MD, FCCP, President of the American College of Chest Physicians. "It is essential that physicians and researchers work to alleviate and eventually cure those ailments caused by this tragedy, as well as any respiratory diseases that may be acquired in other occupational settings."

While researchers are optimistic about the results, they continue to stress that larger studies are required to substantiate these findings. This study was conducted with support from the Investigator-Sponsored Study Program of AstraZeneca, and the use of inhaled corticosteroids may be considered off- label use. The
'/>"/>

SOURCE American College of Chest Physicians
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
2. PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin
3. Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
4. Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be Presented at American Thoracic Society International Conference
5. Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
6. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
7. Point of Care Strep Tests Speed Treatment, Lower Costs
8. Rapid HIV Testing Increases Possibility of Treatment
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... 16 American pharmaceutical manufacturer Alpharma Inc. ... resolve False Claims Act allegations in connection with the ... announced today. The settlement resolves allegations that, between ... , Alpharma paid health care providers to induce them ... the safety and efficacy of the drug, which is ...
(Date:3/16/2010)... , March 16 New research ... in new medicines and vaccines by the U.S. biopharmaceutical ... increase of more than $1.5 billion from ... a combined analysis conducted by Burrill & Company, a ... whose principal activities are in Private Equity, Venture Capital, ...
(Date:3/16/2010)... -- BioVigil LLC has released the second generation of the BioVigil hand hygiene monitoring system. The innovative system enables hospitals to more effectively combat Hospital-Acquired ... ... , ... ... ...
Breaking Medicine Technology:Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 2Alpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection With Promotion of Drug Kadian 3R&D Investment by U.S. Biopharmaceutical Companies Increases to Record $65.3 Billion, Study Finds 2R&D Investment by U.S. Biopharmaceutical Companies Increases to Record $65.3 Billion, Study Finds 3R&D Investment by U.S. Biopharmaceutical Companies Increases to Record $65.3 Billion, Study Finds 4BioVigil Releases Second-Generation Hand Hygiene Monitoring System 2BioVigil Releases Second-Generation Hand Hygiene Monitoring System 3BioVigil Releases Second-Generation Hand Hygiene Monitoring System 4American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China 13124 1American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China 13124 2Weight Watchers Announces Second Quarter 2009 Earnings Conference Call 52240 1Weight Watchers Announces Second Quarter 2009 Earnings Conference Call 52240 2Ortho Clinical Diagnostics Launches 24 Hour Remote Monitoring Center 52238 1Ortho Clinical Diagnostics Launches 24 Hour Remote Monitoring Center 52238 2Ortho Clinical Diagnostics Launches 24 Hour Remote Monitoring Center 52238 3Ortho Clinical Diagnostics Launches 24 Hour Remote Monitoring Center 52238 4
... On February 13, the NYC Department of,Health "unveiled a brand ... media campaign to encourage New Yorker,s to ,get some.," The,Release ... at,"busy crossroads," that the campaign would include ads on TV ... and that over 36 million,condoms were given out last year., ...
... Feb. 19 A natural health company located ... results of,recent clinical studies indicating their oxygen colon ... and Irritable Bowel,Syndrome. In fact, the scientific data ... 85% MORE EFFECTIVE AT ELIMINATING SYMPTOMS,THAN TRADITIONAL LAXATIVES ...
Other Medicine Technology:NYC Department of Health's 'Get Some NYC Condoms' Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters 2Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies 2
(Date:3/16/2010)... Robert Myers , the company,s President, will present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24, 2010 at ... ... , ... ... ...
(Date:3/16/2010)... March 16 TeamHealth Holdings, Inc. ("TeamHealth") ... suppliers of outsourced healthcare professional staffing and administrative services ... United States , today announced that its management will ... Conference on March 24, 2010 , at the ... begin at 9:30 AM Eastern time .  Interested ...
(Date:3/16/2010)... GLEN ALLEN, Va. , March 16 ... report on Form 10-K today with the Securities and Exchange ... for 2009 compared to $0.5 million in ... at year-end 2009 totaled $12.4 million compared with ... for 2009 totaled approximately $(22.8) million compared to ...
(Date:3/16/2010)... March 16, 2010 The AIUM is ... have collaborated with AIUM to endorse the ... of Musculoskeletal Ultrasound Examinations. The guidelines allow ... physicians, podiatrists, and sonographers, to perform musculoskeletal ... future of this growing field. , ...
(Date:3/16/2010)... Newspaper, magazine stories shy away from negative side ... March 16 (HealthDay News) -- People often complain ... when it comes to cancer most newspaper and ... suggest. , The study authors found that articles ... survival, with far less attention given to cancer ...
Breaking Medicine News(10 mins):Health News:Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference 2Health News:TeamHealth Holdings, Inc., to Present at Barclays Capital Global Healthcare Conference 2Health News:TeamHealth Holdings, Inc., to Present at Barclays Capital Global Healthcare Conference 3Health News:Star Scientific Files Annual Financial Report With SEC, Regains Compliance With NASDAQ Minimum Bid-Price Requirement 2Health News:Star Scientific Files Annual Financial Report With SEC, Regains Compliance With NASDAQ Minimum Bid-Price Requirement 3Health News:Star Scientific Files Annual Financial Report With SEC, Regains Compliance With NASDAQ Minimum Bid-Price Requirement 4Health News:Star Scientific Files Annual Financial Report With SEC, Regains Compliance With NASDAQ Minimum Bid-Price Requirement 5Health News:Star Scientific Files Annual Financial Report With SEC, Regains Compliance With NASDAQ Minimum Bid-Price Requirement 6Health News:Unprecedented AIUM training guidelines speak to future of musculoskeletal ultrasound 2Health News:Cancer Articles Tend to Focus on Positive Outcomes 2
... Washington, D.C., and Meet with Elected Officials, WASHINGTON, ... to Washington, D.C., this April 1 to meet with,congressional ... with Disabilities Act, support for epilepsy public health,programs and ... is one of 50 young people with epilepsy participating ...
... Washington, D.C., and Meet with Elected,Officials, WASHINGTON, March ... Washington, D.C., this April 1 to meet,with congressional leaders ... Disabilities Act, support for epilepsy public health,programs and more ... is one of 50 young people with epilepsy participating ...
... and Meet With Elected,Officials, WASHINGTON, March 14 ... this April 1 to meet with,congressional leaders and gain ... support for epilepsy public health,programs and more research toward ... of 50 young people with epilepsy participating in,Kids Speak ...
... Corporation,(NYSE: STE ) today announced that Michael ... president and chief financial officer. Mr. Tokich joined,STERIS ... and corporate,controller. He will report to Walt Rosebrough, ... for financial reporting,financial planning, investor relations, tax, and ...
... High-Fiber Line to its Selection ... of All-Natural Cookies, ... its new line of "Nana,s Fiber Cookie Bars." The,new high-fiber cookie ... cookie. The new Fiber Bar will complement the company,s,existing lines of ...
... aggressive disease and lower survival rates if they are ... March 15 issue of Clinical Cancer Research, a journal ... The more obese a patient is, the more aggressive ... medicine in the Department of Breast Medical Oncology at ...
Other Medicine News:Health News:Florida Youth Named National Epilepsy Spokesperson 2Health News:Vermont Youth Named National Epilepsy Spokesperson 2Health News:Tennessee Youth Named National Epilepsy Spokesperson 2Health News:STERIS Corporation Names Michael J. Tokich Chief Financial Officer 2Health News:STERIS Corporation Names Michael J. Tokich Chief Financial Officer 3Health News:STERIS Corporation Names Michael J. Tokich Chief Financial Officer 4Health News:Have Your Cookie and Fiber too With Nana's Newest Cookie Bar 2Health News:Breast cancer more aggressive among obese women 2
... the Vortex Vacuum Mixer is clinically proven to ... traditional vacuum mixers. The ergonomically angled base means ... crank three revolutions every time you turn ... stirring, cutting down on the amount of air ...
This high technology cast plaster cutter saw is very easy and comfortable to use....
De Soutter supply clean cast removal saws that are low in voltage and contain an integrated extractor system, combining state-of-the-art ergonomics with performance and durability....
The Orengo staple is an oval staple, with thicker and longer legs (25 mm). It is then more especially bound to be used onto thick bones. The design of its stapler makes it more difficult to use und...
Medicine Products: